Last reviewed · How we verify
Prudoxin
At a glance
| Generic name | Prudoxin |
|---|---|
| Sponsor | Aalborg University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism (Phase 4)
- The Use of Doxepin for Urticaria in the Emergency Department (Phase 3)
- A Phase III Placebo-Controlled, Randomized Three-Arm Study of Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy (Phase 3)
- A Randomized Double-Blind Study of Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy (Phase 3)
- Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus: Pilot Study (Phase 4)
- A Prospective Randomized Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program at Eskenazi Hospital (NA)
- A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Proof-of-Concept Study to Evaluate the Safety and Efficacy of Ramelteon Taken in Combination With Doxepin for the T (Phase 2)
- NCT01268709 (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prudoxin CI brief — competitive landscape report
- Prudoxin updates RSS · CI watch RSS
- Aalborg University portfolio CI